FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022256282> ?p ?o ?g. }

• W2022256282 endingPage "178" @default.
• W2022256282 startingPage "171" @default.
• W2022256282 abstract "Drug resistance often critically limits the efficacy of molecular targeted drugs. Although pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) is an attractive therapeutic strategy for cancer therapy, molecular determinants for efficacy of PI3K inhibitors (PI3Kis) remain unclear. We previously identified that overexpression of insulin-like growth factor 1 receptor (IGF1R) contributed to the development of drug resistance after long-term exposure to PI3Kis. In this study, we examined the involvement of basal IGF1R expression in intrinsic resistance of drug-naïve cancer cells to PI3Kis and whether inhibition of IGF1R overcomes the resistance. We found that cancer cells highly expressing IGF1R showed resistance to dephosphorylation of Akt and subsequent antitumor effect by ZSTK474 treatment. Knockdown of IGF1R by siRNAs facilitated the dephosphorylation and enhanced the drug efficacy. These cells expressed tyrosine-phosphorylated insulin receptor substrate 1 at high levels, which was dependent on basal IGF1R expression. In these cells, the efficacy of ZSTK474 in vitro and in vivo was improved by its combination with the IGF1R inhibitor OSI-906. Finally, we found a significant correlation between the basal expression level of IGF1R and the inefficacy of ZSTK474 in an in vivo human cancer panel, as well as in vitro. These results suggest that basal IGF1R expression affects intrinsic resistance of cancer cells to ZSTK474, and IGF1R is a promising target to improve the therapeutic efficacy. The current results provide evidence of combination therapy of PI3Kis with IGF1R inhibitors for treating IGF1R-positive human cancers." @default.
• W2022256282 created "2016-06-24" @default.
• W2022256282 creator A5003695970 @default.
• W2022256282 creator A5004854030 @default.
• W2022256282 creator A5007262286 @default.
• W2022256282 creator A5037088442 @default.
• W2022256282 creator A5038117646 @default.
• W2022256282 creator A5046357734 @default.
• W2022256282 creator A5052447311 @default.
• W2022256282 creator A5056538575 @default.
• W2022256282 creator A5060700088 @default.
• W2022256282 creator A5081587339 @default.
• W2022256282 creator A5091566693 @default.
• W2022256282 date "2015-01-16" @default.
• W2022256282 modified "2023-10-05" @default.
• W2022256282 title "Basal expression of insulin‐like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3‐kinase inhibitor ZSTK474" @default.
• W2022256282 cites W1474539042 @default.
• W2022256282 cites W1841050729 @default.
• W2022256282 cites W1894792990 @default.
• W2022256282 cites W1971008529 @default.
• W2022256282 cites W1977267072 @default.
• W2022256282 cites W1982479748 @default.
• W2022256282 cites W1993248218 @default.
• W2022256282 cites W1998309952 @default.
• W2022256282 cites W2001999652 @default.
• W2022256282 cites W2008720923 @default.
• W2022256282 cites W2009886463 @default.
• W2022256282 cites W2010601523 @default.
• W2022256282 cites W2015325092 @default.
• W2022256282 cites W2027074912 @default.
• W2022256282 cites W2028704745 @default.
• W2022256282 cites W2041808638 @default.
• W2022256282 cites W2042619042 @default.
• W2022256282 cites W2060915586 @default.
• W2022256282 cites W2070732456 @default.
• W2022256282 cites W2075989748 @default.
• W2022256282 cites W2079571554 @default.
• W2022256282 cites W2082170965 @default.
• W2022256282 cites W2088905520 @default.
• W2022256282 cites W2103980474 @default.
• W2022256282 cites W2109600717 @default.
• W2022256282 cites W2113510356 @default.
• W2022256282 cites W2114864550 @default.
• W2022256282 cites W2126783165 @default.
• W2022256282 cites W2129172946 @default.
• W2022256282 cites W2139191784 @default.
• W2022256282 cites W2143945587 @default.
• W2022256282 cites W2147301204 @default.
• W2022256282 cites W2155208683 @default.
• W2022256282 cites W2155228605 @default.
• W2022256282 cites W2161821474 @default.
• W2022256282 cites W2164837623 @default.
• W2022256282 cites W2388163742 @default.
• W2022256282 cites W4238567307 @default.
• W2022256282 doi "https://doi.org/10.1111/cas.12582" @default.
• W2022256282 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4399020" @default.
• W2022256282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25483727" @default.
• W2022256282 hasPublicationYear "2015" @default.
• W2022256282 type Work @default.
• W2022256282 sameAs 2022256282 @default.
• W2022256282 citedByCount "11" @default.
• W2022256282 countsByYear W20222562822015 @default.
• W2022256282 countsByYear W20222562822016 @default.
• W2022256282 countsByYear W20222562822018 @default.
• W2022256282 countsByYear W20222562822020 @default.
• W2022256282 countsByYear W20222562822021 @default.
• W2022256282 countsByYear W20222562822022 @default.
• W2022256282 crossrefType "journal-article" @default.
• W2022256282 hasAuthorship W2022256282A5003695970 @default.
• W2022256282 hasAuthorship W2022256282A5004854030 @default.
• W2022256282 hasAuthorship W2022256282A5007262286 @default.
• W2022256282 hasAuthorship W2022256282A5037088442 @default.
• W2022256282 hasAuthorship W2022256282A5038117646 @default.
• W2022256282 hasAuthorship W2022256282A5046357734 @default.
• W2022256282 hasAuthorship W2022256282A5052447311 @default.
• W2022256282 hasAuthorship W2022256282A5056538575 @default.
• W2022256282 hasAuthorship W2022256282A5060700088 @default.
• W2022256282 hasAuthorship W2022256282A5081587339 @default.
• W2022256282 hasAuthorship W2022256282A5091566693 @default.
• W2022256282 hasBestOaLocation W20222562821 @default.
• W2022256282 hasConcept C121608353 @default.
• W2022256282 hasConcept C126322002 @default.
• W2022256282 hasConcept C144174609 @default.
• W2022256282 hasConcept C170493617 @default.
• W2022256282 hasConcept C2775960820 @default.
• W2022256282 hasConcept C2779438470 @default.
• W2022256282 hasConcept C2780689927 @default.
• W2022256282 hasConcept C502942594 @default.
• W2022256282 hasConcept C62478195 @default.
• W2022256282 hasConcept C71924100 @default.
• W2022256282 hasConcept C75217442 @default.
• W2022256282 hasConcept C86803240 @default.
• W2022256282 hasConcept C95444343 @default.
• W2022256282 hasConcept C98274493 @default.
• W2022256282 hasConceptScore W2022256282C121608353 @default.
• W2022256282 hasConceptScore W2022256282C126322002 @default.
• W2022256282 hasConceptScore W2022256282C144174609 @default.
• W2022256282 hasConceptScore W2022256282C170493617 @default.

• next